MétaCan
Menu
Back to cohort
Record W3014760884 · doi:10.1055/s-0039-3403296

Does brain natriuretic peptide (BNP) at baseline influence the effects of nintedanib plus sildenafil in patients with IPF?

2020· article· en· W3014760884 on OpenAlexaff
Jürgen Behr, Martin Kolb, Horst Olschewski, JW Song, Fabrizio Luppi, Birgit Schinzel, Susanne Stowasser, Manuel Quaresma, F.J. Martinez

Bibliographic record

VenuePneumologie · 2020
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsSt. Joseph’s Healthcare Hamilton
Fundersnot available
KeywordsNintedanibSildenafilMedicineInternal medicineBrain natriuretic peptideCardiologyDLCOClinical endpointNatriuretic peptideRandomized controlled trialHeart failureIdiopathic pulmonary fibrosisLung functionLung

Abstract

fetched live from OpenAlex

Introduction: In the INSTAGE trial in patients with IPF and DLco ≤ 35% predicted, nintedanib plus sildenafil was not associated with a significant benefit on SGRQ total score (primary endpoint) vs. nintedanib alone. However, nintedanib plus sildenafil was associated with stabilisation in BNP, a marker of right ventricular strain, and reduced decline in FVC vs. nintedanib alone. Aim: To assess whether baseline BNP influenced the effects of nintedanib plus sildenafil vs. nintedanib alone. Methods: In post-hoc analyses, patients with baseline BNP ≤ vs. > median were compared on changes from baseline in BNP at week 24 and in SGRQ total score and FVC at weeks 12 and 24; time to absolute FVC ≥ 5% predicted or death; and time to relative FVC decline ≥ 10% predicted or death. Results: At baseline, median BNP was 52 ng/L; 140 patients had BNP ≤ 52 ng/L and 133 had BNP > 52 ng/L. All endpoints showed numerical benefits of nintedanib plus sildenafil vs. nintedanib alone in both subgroups. Compared with patients with baseline BNP below the median, the combination provided a significantly greater benefit on BNP levels and a numerical benefit on FVC in patients with higher baseline BNP. Conclusions: In patients with IPF and severely impaired gas exchange, the benefit of nintedanib plus sildenafil vs. nintedanib alone on changes in BNP and FVC seemed more pronounced in patients with baseline BNP above the median. Table 1 Baseline BNP ≤ 52 ng/L Baseline BNP > 52 ng/L Treatment-by-subgroup-by-time interaction p-value Nintedanib + sildenafil Nintedanib alone Difference (95% CI) Nintedanib + sildenafil Nintedanib alone Difference (95% CI) * These between-group comparisons are expressed as hazard ratios. Mean (SE) change in BNP at week 24, ng/L − 5.44 (15.83) − 0.72 (17.95) − 4.72 (− 50.92, 41.48) − 20.41 (19.34) 72.97 (16.33) − 93.38 (− 142.11, − 44.65) 0.0101 SGRQ total score Mean (SE) change at week 12 − 1.05 (1.32) − 0.54 (1.53) − 0.50 (− 4.48, 3.47) − 1.62 (1.61) − 0.93 (1.37) − 0.69 (− 4.84, 3.46) 0.9501 Mean (SE) change at week 24 0.32 (1.47) 3.18 (1.71) − 2.86 (− 7.31, 1.59) 0.14 (1.87) 1.77 (1.60) − 1.64 (− 6.47, 3.19) 0.7146 FVC, mL Mean (SE) change at week 12 − 18.6 (20.6) − 41.8 (23.6) 23.2 (− 38.5, 84.8) 46.3 (25.0) − 13.7 (21.2) 60.0 (− 4.3, 124.3) 0.4157 Mean (SE) change at week 24 − 68.5 (24.8) − 75.8 (28.6) 7.3 (− 67.2, 81.8) 55.3 (30.8) − 45.6 (26.3) 100.9 (21.4, 180.5) 0.0917 Rate of change in FVC, mL/24 weeks − 65.7 (23.3) − 83.1 (26.5) 17.4 (− 52.7, 87.4) 46.7 (32.7) − 51.6 (27.9) 98.3 (12.9, 183.8) 0.1450 n (%) with absolute FVC decline ≥ 5% predicted or death 26 (32.9) 36 (59.0) 0.48 (0.29, 0.80)* 17 (29.3) 33 (44.0) 0.65 (0.35, 1.18)* 0.3843 n (%) with relative FVC decline ≥ 10% predicted or death 22 (27.8) 22 (36.1) 0.72 (0.39, 1.30)* 13 (22.4) 28 (37.3) 0.63 (0.32, 1.21)* 0.8018 * presented at ERS 2019, ‡ presenting on behalf of the authors

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.270
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuePneumologieSame topicAtrial Fibrillation Management and OutcomesFrench-language works237,207